HF 3805 Minnesota House · 2019-2020 Regular Session

Prescription drug manufacturers required to report and maintain drug prices.

Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2020
Committee Review
Floor Vote
Governor
Introduced Feb 26, 2020 Last action Feb 26, 2020